Astera Labs, Inc. (NASDAQ:ALAB) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have received a consensus rating of “Moderate Buy” from the twenty-two analysts that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $202.2222.

A number of equities analysts have commented on ALAB shares. Morgan Stanley reaffirmed an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Citigroup cut their price target on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Northland Securities upped their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Finally, Royal Bank Of Canada started coverage on Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective for the company.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jack R. Lazar sold 7,500 shares of the company’s stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $119.80, for a total transaction of $898,500.00. Following the completion of the transaction, the director directly owned 87,351 shares in the company, valued at $10,464,649.80. The trade was a 7.91% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 384,292 shares of company stock worth $48,724,919. Insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Assetmark Inc. boosted its position in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Reflection Asset Management purchased a new stake in Astera Labs in the fourth quarter valued at approximately $25,000. Smartleaf Asset Management LLC raised its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the period. Hilltop National Bank lifted its stake in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC acquired a new position in Astera Labs during the fourth quarter worth $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Down 8.0%

Shares of ALAB opened at $116.04 on Monday. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90. The stock has a fifty day simple moving average of $144.10 and a two-hundred day simple moving average of $166.05. The company has a market capitalization of $19.75 billion, a PE ratio of 95.11, a price-to-earnings-growth ratio of 2.28 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter in the previous year, the company posted $0.37 EPS. The company’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.